Axinn partner Aziz Burgy and associate Ross Blau co-authored "Pharmaceutical Supply Chain – Patent Considerations," a chapter in the third edition of the American Bar Association publication, Pre-ANDA Litigation: Strategies and Tactics for Developing a Drug Product and Patent Portfolio. 

Click here to learn more about the publication.